Ultime notizie per Pro Medicus (OTC:PMDIY) Azioni

Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are US private academic hospitals. In fiscal 2022, Pro Medicus earned 79% of revenue in North America, 16% from Australia, and the remaining 6% in Europe.

PRO MEDICUS LTD U/ADR by Pro Medicus, Ltd.

Pro Medicus Ltd

<a href="https://newsroom.intel.com/intel-products/imperial-college-london-chooses-intel-xeon-6-for-hpc-supercomputer" title="https://newsroom.intel.com/intel-products/imperial-college-london-chooses-intel-xeon-6-for-hpc-supercomputer">https://newsroom.intel.com/intel-products/imperial-college-london-chooses-intel-xeon-6-for-hpc-supercomputer</a>

News

INTC

Reported Earlier: 'Imperial College London Chooses Intel Xeon 6 for Latest HPC Supercomputer'

Elon Musk reacted Tuesday to the first public sighting of Tesla Inc.'s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSLA#NASDAQ">TSLA</a>) robotaxi prototype testing without a driver, calling it a <a href="https://www.benzinga.com/markets/tech/25/06/45854273/elon-musks-tesla-officially-named-av-operator-in-austin-ahead-of-robotaxi-launch">"beautifully simple design."</a>
The vehicle was spotted operating on public roads in Austin, Texas, featured in a post on <a class="" href="https://x.com/elonmusk/status/1932487411893944614">X</a>. A video shared by Sawyer Merritt showed the Model Y with Tesla's new "Robotaxi" wordmark on its side and no one in the driver's seat.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Beautifully simple design. <a href="https://t.co/eA7QgzW1jh">https://t.co/eA7QgzW1jh</a>
&mdash; Elon Musk (@elonmusk) <a href="https://twitter.com/elonmusk/status/1932487411893944614?ref_src=twsrc%5Etfw">June 10, 2025</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Musk posted his brief approval—"Beautifully simple design"—shortly after, sparking a flurry of responses. @Mr_Velyo replied, "This is beautifully &#x1f1fa;&#x1f1f8;," while @MikeAnd00183888 wrote, "Love it!!" User @dunck14 added, "And so it begins."
Some questioned the vehicle's tech setup. "How did you hide all the lidars?" asked @LucilleChad, while @neirehebrd posed, "What happens if it malfunctions?"
Also Read: <a>Apple&#8217;s WWDC AI Reveal Sends Chip Stocks Soaring: What Investors Need To Know</a>
Accessibility and rollout timing also surfaced. "Any timeline for unsupervised driving in Canada?" asked @Aiemannzahabi. Meanwhile, @coyotered9 shared, "I've stopped driving because of a medical situation… would I be able to use the car without a driver's license?"
The post marked the first known public test of Tesla's robotaxi with no driver onboard.
Tesla's limited rollout arrives as another player continues accelerating at scale. <a href="https://www.benzinga.com/markets/tech/25/06/45752429/waymos-explosive-growth-sets-the-pace-as-tesla-prepares-robotaxi-launch">Waymo's explosive growth</a> in California has taken monthly ride volume from fewer than 100,000 a year ago to over 700,000 as of June 2025.
The company recently doubled its total paid rides to reach the 10 million milestone in just five months. It plans to double that figure again and hit 20 million by year-end.
Waymo's weekly ride volume now exceeds 250,000 trips across Phoenix, San Francisco, Los Angeles and Austin. In California alone, completed rides jumped from 143,000 in May to more than 312,000 by August 2024.
Tesla's Austin pilot, launching June 12 with about 10 modified Model Y vehicles, marks its first move into live driverless service. The rollout arrives as Waymo prepares to test its AV taxis in new markets, including San Antonio, Houston and Orlando.
Read Next:
<ul class="wp-block-list">
<li> <a>Trump&#8217;s Manufacturing Narrative Weakens As May Data Shows Sharper Contraction, Stubborn Inflation</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Tech

TSLA

Tesla's Robotaxi Spotted Without Driver, But Can It Catch Waymo's Breakneck Lead?

<a href="https://www.cnbc.com/2025/06/10/starbucks-to-roll-out-microsoft-azure-openai-assistant-for-baristas.html">https://www.cnbc.com/2025/06/10/starbucks-to-roll-out-microsoft-azure-openai-assistant-for-baristas.html</a>

General

MSFT

SBUX

'Starbucks to roll out Microsoft Azure OpenAI assistant for baristas'- CNBC

<a href="https://ppubs.uspto.gov/api/pdf/downloadPdf/12326512?requestToken=eyJzdWIiOiJmZDQyZTBlNS04YjA5LTRkMTUtYWQ3NC0zNDRkYmJmOTBkMjMiLCJ2ZXIiOiJlZWM2MmU0Yy1kNjU2LTQ5NDYtYjFiMS1kMTMzZjM5OTg4M2YiLCJleHAiOjB9" title="https://ppubs.uspto.gov/api/pdf/downloadPdf/12326512?requestToken=eyJzdWIiOiJmZDQyZTBlNS04YjA5LTRkMTUtYWQ3NC0zNDRkYmJmOTBkMjMiLCJ2ZXIiOiJlZWM2MmU0Yy1kNjU2LTQ5NDYtYjFiMS1kMTMzZjM5OTg4M2YiLCJleHAiOjB9">https://ppubs.uspto.gov/api/pdf/downloadPdf/12326512?requestToken=eyJzdWIiOiJmZDQyZTBlNS04YjA5LTRkMTUtYWQ3NC0zNDRkYmJmOTBkMjMiLCJ2ZXIiOiJlZWM2MmU0Yy1kNjU2LTQ5NDYtYjFiMS1kMTMzZjM5OTg4M2YiLCJleHAiOjB9</a>

SVRE

SaverOne Awarded Patent US 12326512 B2 Titled "SYSTEM AND METHOD FOR CLASSIFYING A MODE OF OPERATION OF A MOBILE COMMUNICATION DEVICE IN A VOLUME BASED ON SENSOR FUSION"

A quiet M&amp;A desk is a sorry sight for a banker and a lost opportunity for an investor. But that may be about to end. Citigroup has predicted a strong rebound in banking fees this quarter, fueled by increasing equity underwriting and M&amp;A activity, <a href="https://www.reuters.com/business/finance/citi-expects-banking-fees-trading-revenue-climb-despite-us-tariff-anxiety-2025-06-10/">reported</a> Reuters. After a bleak spell of deal famine, the signs are for a fee feast, and <a href="https://www.benzinga.com/etfs">ETF investors</a> might do well to bring a plate.
Citi's forecast suggests mid-single-digit growth in banking fees in the second quarter, alongside a surge in trading revenues. While equities and fixed-income trading are already showing muscle, the advisory and underwriting sides of the business could be gearing up for a comeback.
And when Wall Street feasts, the financial ETFs don't stay hungry for long.
Also Read: <a href="https://www.benzinga.com/etfs/specialty-etfs/25/06/45865293/microsoft-overtakes-nvidia-to-top-3-5-trillion-taking-these-3-etfs-with-it">Microsoft Overtakes Nvidia To Top $3.5 Trillion, Taking These 3 ETFs With It</a>
<h2 class="wp-block-heading">M&amp;A's Are Back On The Menu</h2>
Mergers and IPOs were shelved for most of 2023 and early 2024, courtesy of wild interest rates and recession anxiety. But with inflation cooling and the Fed suggesting a possible rate-cutting cycle, corporate confidence is coming back into play—laying the groundwork for increased deals.
&#8220;Given the amount of capital flowing through M&amp;A—some $3.4 trillion in 2024—and the decades of research showing that programmatic acquirers create more value than peers, investing in M&amp;A capabilities makes sense,&#8221; a February <a href="https://www.mckinsey.com/capabilities/m-and-a/our-insights/top-m-and-a-trends">report </a>by McKinsey &amp; Company said.
&#8220;M&amp;A continues to be super active &#8212; there&#8217;s a lot of dialog, a lot of engagement,&#8221; Citi said in its recent outlook, commenting on improved pipelines in equity capital markets and advisory services. If the momentum continues, fee-based revenue will climb sharply in top banks.
That directly affects ETFs that track financial institutions, especially those more exposed to advisory-heavy banks such as Goldman Sachs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GS#NYSE">GS</a>), JPMorgan (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JPM#NYSE">JPM</a>), and Morgan Stanley (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MS#NYSE">MS</a>).
ETFs That Could Ride The Deal Wave
SPDR Select Sector Fund (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XLF#NYSE">XLF</a>)
Why it&#8217;s important: With heavy weightage to Citi, JPMorgan, Goldman Sachs, and Bank of America, XLF is a front-line winner of increased banking fees. It&#8217;s one of the most liquid sector ETFs, too, ideal for active traders and institutions.
SPDR S&amp;P Bank ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KBE#NYSE">KBE</a>)
Why it matters: Provides equal-weight exposure to large and mid-cap banks. Though more interest-rate spread-sensitive, it would be helped if M&amp;A activity comes to regional players or smaller institutions, which is possible in the current environment.
SPDR S&amp;P Regional Banking ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KRE#NYSE">KRE</a>)
Why it matters: If transactional activity filters down into regional consolidations, most notably in commercial banking, KRE might benefit from acquisition premiums and improved fee margins.
<h2 class="wp-block-heading">Bottom Line</h2>
The fat-fee, fancy-bonus era may not be here yet—but it&#8217;s around the corner. As banks prepare for a wave of deal-making and advisory activity, sector-specific ETFs can potentially provide a low-friction means of accessing the rebound.
And, if Wall Street&#8217;s having a fee feast this quarter, perhaps it&#8217;s time to take a fork and some judiciously selected tickers.
Read Next: 
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/etfs/specialty-etfs/25/06/45869385/silvers-35-breakout-the-best-etfs-for-the-bullish-ride">Silver&#8217;s $35 Breakout: The Best ETFs For The Bullish Ride</a></li>
</ul>
Photo: Shutterstock

Specialty ETFs

ETFs

Citi Sees M&A Rebound: Financial ETFs May Finally Catch A Bid

<a href="https://www.aboutamazon.com/news/innovation-at-amazon/project-kuiper-satellite-rocket-launch-progress-updates">https://www.aboutamazon.com/news/innovation-at-amazon/project-kuiper-satellite-rocket-launch-progress-updates</a>

AMZN

Amazon Says Preparing To Launch Our Next Batch Of Project Kuiper Satellites With United Launch Alliance; KA-02 Mission Will Send Another 27 Satellites Into Orbit

<a href="https://www.businessinsider.com/microsoft-copilot-licenses-million-ai-2025-6">https://www.businessinsider.com/microsoft-copilot-licenses-million-ai-2025-6</a>

'Microsoft is working on a deal to add 1 million Copilot users from a single customer, exec says in internal meeting'- Business Insider

Offerings

FORD

Forward Industries Files For Mixed Shelf Of Up To $50M

CJS Securities analyst Larry Solow initiates coverage on Sensient Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SXT#NYSE">SXT</a>) with a Market Perform rating and announces Price Target of $95.

Price Target

Initiation

Analyst Ratings

CJS Securities Initiates Coverage On Sensient Technologies with Market Perform Rating, Announces Price Target of $95

<a href="https://www.bloomberg.com/news/articles/2025-06-10/whole-foods-supplier-hack-leaves-empty-shelves-stalls-forklifts?embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-06-10/whole-foods-supplier-hack-leaves-empty-shelves-stalls-forklifts?embedded-checkout=true</a>

UNFI

'Whole Foods Supplier Hack Leaves Empty Shelves, Stalls Forklifts'- Bloomberg

After four decades of buying and selling stocks, I&#8217;ve learned that the best investment strategies are deceptively simple. They&#8217;re the kind of ideas that make perfect sense once you hear them but somehow escape the attention of most investors who are too busy chasing the latest hot trend or trying to outsmart the market with complex mathematical models.
One such strategy has been quietly minting money for those smart enough to pay attention: combining deep value with price momentum in the small-cap space. It&#8217;s an approach that flies in the face of conventional wisdom, which insists you must choose between being a value investor or a momentum player. But as I&#8217;ve discovered over the years, some of the market&#8217;s most powerful inefficiencies exist precisely where these two philosophies intersect.
James O&#8217;Shaughnessy codified this approach in what he called the &#8220;Tiny Titans&#8221; strategy. His method was brilliantly simple: buy the cheapest stocks (measured by price-to-sales ratios) that were also showing the strongest price momentum over the past twelve months. Focus on the smallest companies in the market, the true microcaps that most professional investors couldn&#8217;t touch even if they wanted to.
The results spoke for themselves. From 1964 to 2009, this strategy delivered annualized returns north of 21% and more than double the broad market&#8217;s performance. A thousand-dollar investment compounded into nearly $7 million over that period.
Not bad for a strategy you could execute with a basic stock screener and a willingness to own companies most people had never heard of.
But here&#8217;s the thing about markets: they evolve. What worked brilliantly in the 1980s and 1990s faces different challenges today. The microcap space has become cluttered with broken SPACs, penny stock scams, and biotech shells burning through cash with no viable products. Liquidity has become a real problem, and the regulatory environment has made many of these names practically uninvestable for anyone managing serious money.
So let me propose a variation on O&#8217;Shaughnessy&#8217;s theme, one that preserves the essential DNA of Tiny Titans while adapting it for today&#8217;s market realities. Instead of focusing on the absolute smallest companies, we&#8217;ll target what I call the ‘forgotten middle' stocks with market capitalizations between $300 million and $2 billion.
This isn&#8217;t quite microcap territory, but it&#8217;s nowhere near large enough to attract the attention of most institutional investors. These companies exist in a sweet spot: they&#8217;re too small for the big pension funds and mutual funds to bother with, too boring for CNBC to cover, and too illiquid for the high-frequency trading crowd to manipulate effectively.
What you&#8217;re left with is a hunting ground full of misunderstood companies that have survived their awkward adolescent phase and are on the verge of something bigger. When you can buy these businesses at cheap valuations and catch them just as their fortunes are turning, the results can be spectacular.
The strategy itself couldn&#8217;t be simpler. We&#8217;re looking for U.S. companies that meet three criteria:
First, size matters. Market cap between $300 million and $2 billion. Big enough to have real businesses with actual revenue streams, small enough to be ignored by the crowd.
Second, we want them cheap. Price-to-sales ratios in the bottom quartile of the market, ideally under 1.0. This isn&#8217;t about finding the absolute cheapest stocks, it's about finding businesses that are genuinely undervalued relative to their revenue-generating capability.
Third, we want momentum. Not the kind of momentum that comes from short squeezes or Reddit armies, but sustained price appreciation over the past twelve months, which puts these stocks in the top 5% of all performers. We exclude the most recent month to avoid getting caught up in short-term volatility.
The beauty of this combination is that it exploits two of the market&#8217;s most persistent behavioral biases. Investors consistently underreact to improving fundamentals, especially in unloved stocks. And once a stock starts moving higher, performance chasers eventually pile in, creating a self-reinforcing cycle of demand.
The $300 million to $2 billion market cap range represents what I consider the market&#8217;s most fertile ground for contrarian investors. These companies have moved beyond the survival stage that plagues true microcaps, but they haven&#8217;t yet attracted the institutional attention that tends to eliminate pricing inefficiencies.
Many of these businesses are at genuine inflection points&nbsp; are launching new products, expanding into new markets, or achieving profitability for the first time. When Wall Street finally notices what&#8217;s happening, the revaluation can be swift and dramatic.
Consider some examples from recent years.
&nbsp;Boot Barn was trading at half of sales in 2016 during a retail sector pullback. As the western wear retailer&#8217;s margins improved and sentiment shifted, the stock ran from under $10 to over $90.
Enphase Energy was a $300 million solar company trading below 0.5 times sales in 2017. As demand for microinverters exploded, early investors enjoyed a 100-bagger return.
These weren&#8217;t lucky picks or hot tips from Wall Street analysts. They were systematic discoveries using a disciplined screening process that identified cheap stocks with improving momentum.
Momentum gets a bad rap in value investing circles, but I&#8217;ve found it to be an essential filter for separating genuinely improving businesses from permanent value traps. The key is using the right time frame.
Twelve-month momentum, excluding the most recent month, has proven to be the gold standard. It&#8217;s long enough to filter out random noise and short-term manipulation, but responsive enough to catch businesses in the early stages of a turnaround or growth acceleration.
Some practitioners also incorporate six-month momentum as a confirmation signal. If a stock is performing well over both time frames, you&#8217;re probably looking at a genuine trend rather than a temporary blip.
This isn&#8217;t a set-it-and-forget-it strategy. You&#8217;ll need to rebalance monthly, selling any names that no longer meet the criteria and adding new ones that do. You&#8217;ll own some obscure companies that your friends have never heard of.
But you&#8217;ll also own some of the market&#8217;s biggest winners before they become obvious to everyone else.
After decades of watching markets cycle through various fads and fashions, I&#8217;ve come to appreciate strategies that are both simple to understand and grounded in solid behavioral finance principles. The combination of value and momentum in small-cap stocks represents one of the market&#8217;s most enduring inefficiencies.
By focusing on the $300 million to $2 billion market cap range, we can capture most of the upside potential of the original Tiny Titans strategy while avoiding many of the practical problems that plague true microcap investing.
The market will always offer opportunities to those willing to look where others won&#8217;t. In a world obsessed with mega-cap growth stocks and the latest meme stock craze, some of the best values are hiding in plain sight among the forgotten companies that are quietly building real businesses and generating genuine momentum.
Cheap stocks that are going up tend to keep going up. It&#8217;s a simple truth that has created fortunes for those disciplined enough to act on it. The next generation of Tiny Titans is out there waiting to be discovered.
Here are three companies that currently pass out momentum and value filters and could be huge winners:
OppFi operates in that uncomfortable corner of finance that makes most investors squirm: subprime lending. Trading at just 0.5 times sales with a $250 million market cap, this Chicago-based company partners with community banks to extend credit to the 60 million Americans who get turned away by mainstream lenders.
Here&#8217;s what caught my attention: the company just posted 112% net income growth in 2024 while everyone else in fintech is struggling. They&#8217;re generating $526 million in trailing revenue by doing something banks won&#8217;t—lending to people with imperfect credit at higher rates, but with technology-driven underwriting that actually works.
The bears will tell you subprime lending is risky, and they&#8217;re right. But OppFi uses advanced data analytics and machine learning to assess creditworthiness efficiently, and their loss ratios have been improving. Sometimes the businesses everyone avoids are exactly where the money is hiding.
Stitch Fix Inc. (Ticker: SFIX) &#8211; The Comeback Story Wall Street Forgot
Stitch Fix was once the darling of Silicon Valley, going public in 2017 with a $1.6 billion valuation. Today, it&#8217;s a wounded bird that&#8217;s starting to show signs of life. The company just beat Q2 expectations with revenue of $312.1 million and managed to achieve a 710 basis point sequential improvement in year-over-year revenue comps.
The business model remains compelling: they send you clothing they think you&#8217;ll like, you keep what you want and send back the rest. It&#8217;s retail meets data science, and when it works, it&#8217;s magical. Both their Men&#8217;s business and Freestyle channel returned to year-over-year revenue growth, suggesting the turnaround strategy is gaining traction.
Founder Katrina Lake returned as interim CEO in January 2023 after the previous management team couldn&#8217;t execute. Sometimes it takes a founder to fix what&#8217;s broken. The stock has been beaten up enough that modest improvements could generate substantial returns.
Universal Insurance Holdings (Ticker: UVE) &#8211; Florida&#8217;s Hurricane Specialist
Universal Insurance operates in the one place most insurers fear to tread: Florida&#8217;s hurricane-prone coastline. With a current stock price of $23.16 and market cap of $636.4 million, this isn&#8217;t a company for the risk-averse.
But here&#8217;s what&#8217;s interesting: they just reported Q4 2024 results with direct premiums written up 8.8% year-over-year to $470.9 million, despite facing three hurricanes (Debbie, Helene, and Milton). The company maintains relationships with 3,214 independent insurance agencies across 32 states and uses sophisticated risk assessment algorithms.
They&#8217;ve secured 92% placement of their 2025 first event catastrophe tower and additional multi-year capacity for the 2026 hurricane season. In an industry where most players are fleeing Florida, UVE has figured out how to price risk appropriately and stay profitable. Sometimes the best opportunities exist where others fear to go.
Each of these companies operates in markets that make institutional investors nervous—subprime lending, troubled retail, and hurricane insurance.
Each also have momentum building that could provide the buying pressure to send the shares dramatically higher.

Opinion

SFIX

Under the Radar: 21% Annual Returns? This Value-Momentum Strategy Delivered for Decades

<a href="https://www.bloomberg.com/news/articles/2025-06-10/trump-poised-to-repeal-biden-s-curbs-on-power-plant-pollution?embedded-checkout=true">https://www.bloomberg.com/news/articles/2025-06-10/trump-poised-to-repeal-biden-s-curbs-on-power-plant-pollution?embedded-checkout=true</a>

'Trump Poised to Repeal Biden's Curbs on Power-Plant Pollution'- Bloomberg

WIIM

DKNG

DraftKings shares are trading higher in possible reaction to competitor Flutter raising announcing an Illinois betting fee.

<a href="https://www.theinformation.com/articles/google-offers-buyouts-employees-search-ads-unit">https://www.theinformation.com/articles/google-offers-buyouts-employees-search-ads-unit</a>

GOOG

GOOGL

'Google Offers Buyouts to Employees in Search and Ads Unit'- The Information

Politics

Economics

Reuters Reports U.S. Commerce Secretary Lutnick Reportedly Says We Will Try To Finish Things; Talks Are Going Really Well, Hope They End This Evening; China Trade Talks Could Go Into Tomorrow

<a href="https://www.axios.com/2025/06/10/trump-netanyahu-call-iran-military-option">https://www.axios.com/2025/06/10/trump-netanyahu-call-iran-military-option</a>

'Trump told Netanyahu he still wants to defuse Iran crisis with talks, not bombs'- Axios

Meta Platforms Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/META#NASDAQ">META</a>) is entering its most statistically favorable 30-day stretch of the year, with a track record of consistently strong returns from June 11 to July 11 over <a href="https://www.benzinga.com/topic/seasonality">the past 13 years. </a>
With shares trading at $698 on Tuesday, around 6% below their all-time high of $740 reached on Feb. 14, the stage may be set for a fresh breakout of record levels. 
<h1 class="wp-block-heading">A Remarkably Reliable Seasonal Pattern For Meta</h1>
Historical data from Seasonax shows that Meta shares have delivered gains in 12 out of the past 13 years during this specific 30-day window. 
The average return in this period is 6.3%, with a median gain of 6.5%. The best return came in 2012 with a 14.68% rise, while 2022 marked the only losing year, with a modest 0.84% dip.
The standard deviation of returns is 4.49%, suggesting a fairly tight range of performance.
What makes this period especially compelling isn't just the strong gains, but how rarely those runs are interrupted by meaningful drawdowns.
Of the 12 positive years, only three saw a drawdown greater than 2% during the month: 2014 (-4.59%), 2016 (-4.37%) and 2020 (-3.72%). 
Most of the time, intra-period pullbacks were either negligible or non-existent. For instance, in 2012, 2018 and 2023, the stock never dropped from the starting level during the entire 30-day stretch.
Even in the years with double-digit gains — 2012 (+14.68%), 2015 (+10.11%), 2019 (+12.99%) and 2023 (+10.05%) — drawdowns were capped at 1.72% or less, underlining how steady the climb tends to be.
Based on historical returns, if Meta follows its typical trend for this 30-day period, the stock could rise by $44 — bringing it near $742 by mid-July.
So far in 2025, Meta is up 19% year-to-date, outperforming the broader Nasdaq 100 index, which is up 4%, and is helped by robust earnings and aggressive monetization of its AI products.
In its April report, Meta showed revenue growth of 16% year over year to $42.3 billion and earnings per share of $6.43, up 35%.
<figure class="wp-block-table is-style-stripes"> 
<table class="has-fixed-layout">
<tbody>
<tr>
<td>Start date</td>
<td>Start price</td>
<td>End date</td>
<td>End price</td>
<td>Profit %</td>
<td>Max intra-month drawdown</td>
</tr>
<tr>
<td>11 June 2012</td>
<td>26.88</td>
<td>11 July 2012</td>
<td>30.82</td>
<td>+14.68%</td>
<td>0.00%</td>
</tr>
<tr>
<td>11 June 2013</td>
<td>23.92</td>
<td>11 July 2013</td>
<td>25.69</td>
<td>+7.41%</td>
<td>-1.66%</td>
</tr>
<tr>
<td>11 June 2014</td>
<td>65.47</td>
<td>11 July 2014</td>
<td>66.03</td>
<td>+0.85%</td>
<td>-4.59%</td>
</tr>
<tr>
<td>11 June 2015</td>
<td>81.45</td>
<td>13 July 2015</td>
<td>89.68</td>
<td>+10.11%</td>
<td>-1.37%</td>
</tr>
<tr>
<td>13 June 2016</td>
<td>113.42</td>
<td>11 July 2016</td>
<td>117.32</td>
<td>+3.44%</td>
<td>-4.37%</td>
</tr>
<tr>
<td>12 June 2017</td>
<td>147.74</td>
<td>11 July 2017</td>
<td>154.54</td>
<td>+4.60%</td>
<td>-0.01%</td>
</tr>
<tr>
<td>11 June 2018</td>
<td>190.64</td>
<td>11 July 2018</td>
<td>201.59</td>
<td>+5.74%</td>
<td>0.00%</td>
</tr>
<tr>
<td>11 June 2019</td>
<td>177.26</td>
<td>11 July 2019</td>
<td>200.29</td>
<td>+12.99%</td>
<td>-1.72%</td>
</tr>
<tr>
<td>11 June 2020</td>
<td>223.38</td>
<td>13 July 2020</td>
<td>237.88</td>
<td>+6.49%</td>
<td>-3.72%</td>
</tr>
<tr>
<td>11 June 2021</td>
<td>329.71</td>
<td>12 July 2021</td>
<td>351.50</td>
<td>+6.61%</td>
<td>-0.48%</td>
</tr>
<tr>
<td>13 June 2022</td>
<td>163.49</td>
<td>11 July 2022</td>
<td>162.12</td>
<td>-0.84%</td>
<td>-5.12%</td>
</tr>
<tr>
<td>12 June 2023</td>
<td>269.78</td>
<td>11 July 2023</td>
<td>296.89</td>
<td>+10.05%</td>
<td>0.00%</td>
</tr>
<tr>
<td>11 June 2024</td>
<td>505.63</td>
<td>11 July 2024</td>
<td>511.34</td>
<td>+1.13%</td>
<td>-2.40%</td>
</tr>
</tbody>
</table>
<figcaption class="wp-element-caption">Source: Seasonax</figcaption></figure>
Read Now:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/markets/tech/25/06/45866333/qualcomm-unveils-smart-glasses-gen-ai-without-phone-or-cloud-beginning-of-something-huge">Qualcomm Unveils Smart Glasses Gen AI Without Phone Or Cloud: &#8216;Beginning Of Something Huge&#8217;</a> Photo: Shutterstock<a href="https://www.benzinga.com/markets/tech/25/06/45866333/qualcomm-unveils-smart-glasses-gen-ai-without-phone-or-cloud-beginning-of-something-huge"> </a></li>
</ul>

Large Cap

Econ #s

Trading Ideas

Meta Platforms Enters Its Most Bullish Month: A Return To Record Highs In Sight?

Throughout the last three months, 10 analysts have evaluated Globant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLOB#NYSE">GLOB</a>), offering a diverse set of opinions from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">3</td>
<td align="right">4</td>
<td align="right">3</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Analysts have recently evaluated Globant and provided 12-month price targets. The average target is $143.3, accompanied by a high estimate of $225.00 and a low estimate of $115.00. A decline of 22.87% from the prior average price target is evident in the current average. 
<img src="https://www.benzinga.com/files/images/story/2025/1749582125_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
A comprehensive examination of how financial experts perceive Globant is derived from recent analyst actions. The following is a detailed summary of key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Jonathan Lee</td>
<td>Guggenheim</td>
<td>Maintains</td>
<td>Buy</td>
<td>$125.00</td>
<td>$125.00</td>
</tr>
<tr>
<td>Dan Dolev</td>
<td>Mizuho</td>
<td>Lowers</td>
<td>Outperform</td>
<td>$153.00</td>
<td>$194.00</td>
</tr>
<tr>
<td>James Schneider</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$120.00</td>
<td>$225.00</td>
</tr>
<tr>
<td>Arvind Ramnani</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$116.00</td>
<td>$154.00</td>
</tr>
<tr>
<td>Jonathan Lee</td>
<td>Guggenheim</td>
<td>Lowers</td>
<td>Buy</td>
<td>$125.00</td>
<td>$150.00</td>
</tr>
<tr>
<td>Mayank Tandon</td>
<td>Needham</td>
<td>Lowers</td>
<td>Buy</td>
<td>$115.00</td>
<td>$130.00</td>
</tr>
<tr>
<td>Divya Goyal</td>
<td>Scotiabank</td>
<td>Lowers</td>
<td>Sector Perform</td>
<td>$140.00</td>
<td>$170.00</td>
</tr>
<tr>
<td>James Friedman</td>
<td>Susquehanna</td>
<td>Lowers</td>
<td>Positive</td>
<td>$160.00</td>
<td>$225.00</td>
</tr>
<tr>
<td>Arvind Ramnani</td>
<td>Piper Sandler</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$154.00</td>
<td>$230.00</td>
</tr>
<tr>
<td>James Friedman</td>
<td>Susquehanna</td>
<td>Lowers</td>
<td>Positive</td>
<td>$225.00</td>
<td>$255.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: In response to dynamic market conditions and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their reaction to recent developments related to Globant. This insight gives a snapshot of analysts' perspectives on the current state of the company.</li>
<li>Rating: Offering a comprehensive view, analysts assess stocks qualitatively, spanning from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Globant compared to the broader market.</li>
<li>Price Targets: Analysts provide insights into price targets, offering estimates for the future value of Globant's stock. This comparison reveals trends in analysts' expectations over time.</li>
</ul>
Assessing these analyst evaluations alongside crucial financial indicators can provide a comprehensive overview of Globant's market position. Stay informed and make well-judged decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/GLOB/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Globant analyst ratings.</a>
<h2>Discovering Globant: A Closer Look</h2>
Globant is a next-generation IT services company that primarily assists clients with their digital transformation efforts by creating customized software for them. The company was founded in 2003 in Argentina but is currently headquartered in Luxembourg and primarily serves clients in the US and Latin America. Globant's client base is relatively concentrated in the media and entertainment and financial services industries.
<h3>Understanding the Numbers: Globant's Finances</h3>
Market Capitalization Analysis: The company exhibits a lower market capitalization profile, positioning itself below industry averages. This suggests a smaller scale relative to peers.
Revenue Growth: Globant's revenue growth over a period of 3M has been noteworthy. As of 31 March, 2025, the company achieved a revenue growth rate of approximately 7.01%. This indicates a substantial increase in the company's top-line earnings. When compared to others in the Information Technology sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: The company's net margin is a standout performer, exceeding industry averages. With an impressive net margin of 5.01%, the company showcases strong profitability and effective cost control.
Return on Equity (ROE): Globant's ROE is below industry averages, indicating potential challenges in efficiently utilizing equity capital. With an ROE of 1.53%, the company may face hurdles in achieving optimal financial returns.
Return on Assets (ROA): Globant's ROA stands out, surpassing industry averages. With an impressive ROA of 0.96%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Globant's debt-to-equity ratio is below the industry average. With a ratio of 0.2, the company relies less on debt financing, maintaining a healthier balance between debt and equity, which can be viewed positively by investors.
<h2>The Core of Analyst Ratings: What Every Investor Should Know</h2>
Analyst ratings serve as essential indicators of stock performance, provided by experts in banking and financial systems. These specialists diligently analyze company financial statements, participate in conference calls, and engage with insiders to generate quarterly ratings for individual stocks.
In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

GLOB

Forecasting The Future: 10 Analyst Projections For Globant

Analysts' ratings for Controladora Vuela (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VLRS#NYSE">VLRS</a>) over the last quarter vary from bullish to bearish, as provided by 5 analysts.
In the table below, you'll find a summary of their recent ratings, revealing the shifting sentiments over the past 30 days and comparing them to the previous months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $7.82, along with a high estimate of $13.00 and a low estimate of $4.50. Experiencing a 36.53% decline, the current average is now lower than the previous average price target of $12.32. 
<img src="https://www.benzinga.com/files/images/story/2025/1749582102_0.png" alt="price target chart" />
<h2>Analyzing Analyst Ratings: A Detailed Breakdown</h2>
An in-depth analysis of recent analyst actions unveils how financial experts perceive Controladora Vuela. The following summary outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Bruno Amorim</td>
<td>Goldman Sachs</td>
<td>Lowers</td>
<td>Buy</td>
<td>$8.60</td>
<td>$9.60</td>
</tr>
<tr>
<td>Alberto Valerio</td>
<td>UBS</td>
<td>Lowers</td>
<td>Buy</td>
<td>$6.00</td>
<td>$12.00</td>
</tr>
<tr>
<td>Fernando Abdalla</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$7.00</td>
<td>$13.00</td>
</tr>
<tr>
<td>Pablo Monsivais</td>
<td>Barclays</td>
<td>Lowers</td>
<td>Equal-Weight</td>
<td>$4.50</td>
<td>$12.00</td>
</tr>
<tr>
<td>Fernando Abdalla</td>
<td>JP Morgan</td>
<td>Lowers</td>
<td>Overweight</td>
<td>$13.00</td>
<td>$15.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Controladora Vuela. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Offering insights into predictions, analysts assign qualitative values, from 'Outperform' to 'Underperform'. These ratings convey expectations for the relative performance of Controladora Vuela compared to the broader market.</li>
<li>Price Targets: Analysts predict movements in price targets, offering estimates for Controladora Vuela's future value. Examining the current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
To gain a panoramic view of Controladora Vuela's market performance, explore these analyst evaluations alongside essential financial indicators. Stay informed and make judicious decisions using our Ratings Table.
<a href="https://www.benzinga.com/quote/VLRS/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on Controladora Vuela analyst ratings.</a>
If you are interested in following small-cap stock news and performance <a href="https://www.benzinga.com/news/small-cap?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">you can start by tracking it here</a>.
<h2>Discovering Controladora Vuela: A Closer Look</h2>
Controladora Vuela Compania de Aviacion SAB de CV is a low-cost airline flying to Mexico, the United States, Central, and South America. It uses promotional fares to stimulate demand, and the base fares are priced to compete with long-distance bus fares in Mexico. Revenues from the air transportation of passengers are recognized earlier when the service is provided or when the non-refundable ticket expires on the date of the scheduled travel. Non-passenger revenues include revenues generated from other non-passenger services and cargo services. The Company has two geographic areas identified as domestic (Mexico) and international (United States of America, Central America, and South America).
<h3>Controladora Vuela's Economic Impact: An Analysis</h3>
Market Capitalization Analysis: The company's market capitalization is below the industry average, suggesting that it is relatively smaller compared to peers. This could be due to various factors, including perceived growth potential or operational scale.
Revenue Challenges: Controladora Vuela's revenue growth over 3M faced difficulties. As of 31 March, 2025, the company experienced a decline of approximately -11.72%. This indicates a decrease in top-line earnings. As compared to competitors, the company encountered difficulties, with a growth rate lower than the average among peers in the Industrials sector.
Net Margin: Controladora Vuela's net margin lags behind industry averages, suggesting challenges in maintaining strong profitability. With a net margin of -7.52%, the company may face hurdles in effective cost management.
Return on Equity (ROE): Controladora Vuela's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -15.0%, the company may encounter challenges in delivering satisfactory returns for shareholders.
Return on Assets (ROA): Controladora Vuela's ROA stands out, surpassing industry averages. With an impressive ROA of -0.9%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: Controladora Vuela's debt-to-equity ratio is notably higher than the industry average. With a ratio of 12.15, the company relies more heavily on borrowed funds, indicating a higher level of financial risk.
<h2>The Significance of Analyst Ratings Explained</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts publish their predictions for metrics such as growth estimates, earnings, and revenue to provide additional guidance with their ratings. When using analyst ratings, it is important to keep in mind that stock and sector analysts are also human and are only offering their opinions to investors.
If you want to keep track of which analysts are outperforming others, you can view updated analyst ratings along withanalyst success scores in <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

VLRS

Forecasting The Future: 5 Analyst Projections For Controladora Vuela

Whales with a lot of money to spend have taken a noticeably bullish stance on Vale.
Looking at options history for Vale (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/VALE#NYSE">VALE</a>) we detected 8 trades.
If we consider the specifics of each trade, it is accurate to state that 62% of the investors opened trades with bullish expectations and 37% with bearish.
From the overall spotted trades, 6 are puts, for a total amount of $749,694 and 2, calls, for a total amount of $99,507.
<h3>Projected Price Targets</h3>
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $8.0 and $10.0 for Vale, spanning the last three months.
<h3>Analyzing Volume &amp; Open Interest</h3>
Examining the volume and open interest provides crucial insights into stock research. This information is key in gauging liquidity and interest levels for Vale's options at certain strike prices. Below, we present a snapshot of the trends in volume and open interest for calls and puts across Vale's significant trades, within a strike price range of $8.0 to $10.0, over the past month.
<h3>Vale Option Volume And Open Interest Over Last 30 Days</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1749582091_0.png" alt="Options Call Chart" />
<h3>Largest Options Trades Observed:</h3>

<table>
<thead>
<tr>
<th>Symbol</th>
<th>PUT/CALL</th>
<th>Trade Type</th>
<th>Sentiment</th>
<th>Exp. Date</th>
<th>Ask</th>
<th>Bid</th>
<th>Price</th>
<th>Strike Price</th>
<th>Total Trade Price</th>
<th>Open Interest</th>
<th>Volume</th>
</tr>
</thead>
<tbody>
<tr>
<td>VALE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$1.61</td>
<td>$1.54</td>
<td>$1.61</td>
<td>$10.00</td>
<td>$410.5K</td>
<td>148.7K</td>
<td>2.5K</td>
</tr>
<tr>
<td>VALE</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$1.66</td>
<td>$1.61</td>
<td>$1.61</td>
<td>$10.00</td>
<td>$80.5K</td>
<td>148.7K</td>
<td>5.0K</td>
</tr>
<tr>
<td>VALE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$1.61</td>
<td>$1.59</td>
<td>$1.61</td>
<td>$10.00</td>
<td>$78.8K</td>
<td>148.7K</td>
<td>6.5K</td>
</tr>
<tr>
<td>VALE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/15/27</td>
<td>$1.61</td>
<td>$1.59</td>
<td>$1.61</td>
<td>$10.00</td>
<td>$78.8K</td>
<td>148.7K</td>
<td>6.0K</td>
</tr>
<tr>
<td>VALE</td>
<td>PUT</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/15/27</td>
<td>$1.73</td>
<td>$1.59</td>
<td>$1.61</td>
<td>$10.00</td>
<td>$75.6K</td>
<td>148.7K</td>
<td>7.0K</td>
</tr>
</tbody>
</table>

<h3>About Vale</h3>
Vale is a large global miner and the world's largest producer of iron ore and pellets. In recent years the company has sold noncore assets such as its fertilizer, coal, and steel operations to concentrate on iron ore, nickel, and copper. Earnings are dominated by the bulk materials division, primarily iron ore and iron ore pellets. The base metals division is much smaller, consisting of nickel mines and smelters along with copper mines producing copper in concentrate. In 2024, Vale sold a minority 10% stake in energy transition metals, its base metals business, likely the first step in separating base metals and iron ore.
After a thorough review of the options trading surrounding Vale, we move to examine the company in more detail. This includes an assessment of its current market status and performance.
<h3>Present Market Standing of Vale</h3>
<ul>
<li>With a trading volume of 23,837,490, the price of VALE is up by 0.21%, reaching $9.6.</li>
<li>Current RSI values indicate that the stock is is currently neutral between overbought and oversold.</li>
<li>Next earnings report is scheduled for 44 days from now.</li>
</ul>
<h3>Expert Opinions on Vale</h3>
Over the past month, 1 industry analysts have shared their insights on this stock, proposing an average target price of $11.3.
Turn $1000 into $1270 in just 20 days?
20-year pro options trader reveals his one-line chart technique that shows when to buy and sell. Copy his trades, which have had averaged a 27% profit every 20 days. <a href="https://www.benzinga.com/premium/ideas/options-moneyline-2/?t=Moop1arja3be22op14&amp;adType=benzinga-insights&amp;ad=options-activity&amp;campaign=wallstreetadvantage">Click here for access</a>. 
&#x2A; An analyst from CICC has revised its rating downward to Outperform, adjusting the price target to $11. 
Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Vale with <a href="https://www.benzinga.com/pro/">Benzinga Pro</a> for real-time alerts.

Comments

Pro Medicus

Notizie

Ultime notizie per Pro Medicus (OTC:PMDIY) Azioni

Notizie

PARTNER/COLLABORATORE

BENZINGA NEL MONDO